KEAP1 and neoplasm: Importantly, in vitro, isogenic loss of KEAP1 does not result in decreased sensitivity to G12Ci [57], which suggests that the resistance observed in patients is not cell intrinsic, and thus may be mediated by a change in the tumour microenvironment which is absent in the cell culture setting.